全文获取类型
收费全文 | 2514篇 |
免费 | 169篇 |
国内免费 | 301篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 74篇 |
妇产科学 | 26篇 |
基础医学 | 268篇 |
口腔科学 | 39篇 |
临床医学 | 303篇 |
内科学 | 468篇 |
皮肤病学 | 49篇 |
神经病学 | 158篇 |
特种医学 | 341篇 |
外国民族医学 | 3篇 |
外科学 | 115篇 |
综合类 | 295篇 |
预防医学 | 160篇 |
眼科学 | 55篇 |
药学 | 306篇 |
2篇 | |
中国医学 | 105篇 |
肿瘤学 | 211篇 |
出版年
2023年 | 15篇 |
2022年 | 26篇 |
2021年 | 56篇 |
2020年 | 49篇 |
2019年 | 61篇 |
2018年 | 52篇 |
2017年 | 38篇 |
2016年 | 40篇 |
2015年 | 67篇 |
2014年 | 106篇 |
2013年 | 101篇 |
2012年 | 122篇 |
2011年 | 143篇 |
2010年 | 107篇 |
2009年 | 115篇 |
2008年 | 114篇 |
2007年 | 205篇 |
2006年 | 105篇 |
2005年 | 121篇 |
2004年 | 82篇 |
2003年 | 66篇 |
2002年 | 61篇 |
2001年 | 50篇 |
2000年 | 56篇 |
1999年 | 54篇 |
1998年 | 105篇 |
1997年 | 103篇 |
1996年 | 90篇 |
1995年 | 79篇 |
1994年 | 74篇 |
1993年 | 66篇 |
1992年 | 30篇 |
1991年 | 29篇 |
1990年 | 33篇 |
1989年 | 61篇 |
1988年 | 46篇 |
1987年 | 36篇 |
1986年 | 38篇 |
1985年 | 29篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 27篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 16篇 |
1976年 | 28篇 |
1975年 | 13篇 |
排序方式: 共有2984条查询结果,搜索用时 15 毫秒
101.
Monoclonal antibody BA-1 binds to B lymphocytes, to cells from most cases of non-T acute lymphoblastic leukemia (ALL), and weakly to neutrophils. To determine whether BA-1 also reacts with hematopoietic progenitor cells (HPC), we studied the effect of removal of BA-1+ cells from human bone marrow on the proliferation in vitro of the trilineage precursor cell CFU-GEMM, and on the committed progenitor cells of granulopoiesis (CFU-C) and erythropoiesis (BFU-E/CFU-E). Complement- mediated cytotoxicity using BA-1 at concentrations far beyond those required to lyse BA-1+ bone marrow cells and ALL cells did not result in inhibition of colony formation in any of the assays. A rosette separation method, using ox red blood cells coated with BA-1, resulted in enrichment of HPC in the BA-1-depleted interface, whereas very few HPC were found in the BA-1-enriched pellet. Both methods indicate that BA-1 does not bind to HPC, although binding of the antibody to the lymphohematopoietic stem cell cannot be excluded yet. The high cytotoxic capacity of the IgM antibody BA-1, and the lack of reactivity with HPC, make the antibody particularly suitable for use in autologous bone marrow transplantation for patients with ALL. 相似文献
102.
Dammacco F; Sansonno D; Han JH; Shyamala V; Cornacchiulo V; Iacobelli AR; Lauletta G; Rizzi R 《Blood》1994,84(10):3336-3343
Type II mixed cryoglobulinemia (MC) is an often progressive vasculitis characterized by circulating cold-precipitable proteins that usually consists of polyclonal IgG and monoclonal IgM kappa with rheumatoid factor (RF) activity. Its etiology is unknown, although recent evidence strongly suggests that hepatitis C virus (HCV) plays a major role. Plasmapheresis, corticosteroids, and cytotoxic drugs have been used in the therapy of MC patients. Recently, favorable results with recombinant interferon-alpha (rIFN alpha) have been reported. To further assess its effectiveness, we studied the effects of natural human interferon-alpha (nIFN alpha), alone and in combination with 6- methyl-prednisolone (PDN), in a prospective, randomized, controlled trial in patients with symptomatic MC. Sixty-five patients were enrolled onto the trial, 52 (80%) of whom presented serum anti-HCV antibodies and specific genomic RNA sequences. Fifteen patients received nIFN alpha (3 MU) intramuscularly (IM) three times weekly, whereas 17 patients also received 16 mg/d of PDN orally on non-IFN days. Moreover, 18 patients received 16 mg/d of PDN only, and 15 were untreated. Treatment was discontinued after 1 year and patients were monitored for 8 to 17 months (mean, 13). A complete response was achieved in eight of 15 patients (53.3%) treated with nIFN alpha and nine of 17 (52.9%) treated with nIFN alpha plus PDN, as compared with three of 18 patients (16.7%) who received PDN only (P < .05) and one of 15 (6.7%) untreated controls (P < .01). Partial response occurred in two of 15 (13.3%) patients treated with nIFN alpha, three of 17 (17.6%) who received nIFN alpha plus PDN, one of 18 (5.5%) who received PDN only, and one of 15 (6.7%) controls. A complete response in six patients (66.7%) was achieved within 3 months in the group that received nIFN alpha plus PDN, as compared with two patients (25%) of those who received nIFN alpha alone (P < .02). In anti-HCV-positive patients, the clinical response occurred in step with reduced or undetectable levels of HCV RNA and transaminase normalization. Quantification of circulating HCV RNA represented a good predictive response marker. The probability of relapse within 3 months after treatment was 100% (three of three patients) and 75% (six of eight patients), respectively, in patients who received PDN alone or nIFN alpha alone as compared with none of those who received nIFN alpha plus PDN (P < .001).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
103.
104.
Baka is a platelet alloantigen whose putative allele, Bakb, has not been identified previously. By using a serum, "Har," obtained from a patient with posttransfusion purpura, we describe the platelet alloantigen Bakb. The Har serum reacted with an NP-40-extractable platelet membrane protein of 142 kd with mobility similar to platelet glycoprotein IIb alpha. We found that the antigen recognized by the Har serum is inherited in an autosomal dominant mode with an apparent gene frequency of .39. Chi-square analysis of observed and expected phenotype frequencies indicated that serum Har recognizes Bakb, the anticipated allele of Baka. Our findings provide new evidence for polymorphism of glycoprotein IIb and for the association of posttransfusion purpura with alloimmunization to determinants on this glycoprotein. 相似文献
105.
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation 总被引:2,自引:0,他引:2
Bertram JH; Gill PS; Levine AM; Boquiren D; Hoffman FM; Meyer P; Mitchell MS 《Blood》1986,68(3):752-761
Eight patients with cutaneous T cell lymphomas (CTCL) and five with various other T cell malignancies were treated with mouse monoclonal antibody (MoAb) T101. Doses of 1 to 500 mg were administered weekly over a two-hour period and resulted in one complete remission (convoluted T cell lymphoma) and one partial remission (CTCL). Remission duration was 6 weeks and 3 months, respectively. Frequent toxicities were pruritus, hives, flushing, and shortness of breath. Supraventricular arrhythmias and blood pressure instability were also observed. Complete targeting of peripheral blood T cells was achieved with 1 mg of MoAb in the nonleukemic patients (WBC less than 10,000/microL), and free, bioavailable antibody was present at the next (10-mg) dose level. Even higher doses resulted in substantial antibody excess that persisted for as long as 6 weeks. Serum concentrations of MoAb decreased with increasing number of peripheral blood T cells, and 25 to 35 mg of T101 were required for induction of antibody excess in leukemic patients. Excess antibody induced antigenic modulation, which was of consequence only if MoAb excess persisted to the next treatment. In the original treatment, the rapidly administered MoAb was able to target and remove peripheral blood T cells before the development of antigenic modulation. Antimouse antibodies developed in three patients. Their presence rendered further therapy ineffective and was associated with an anaphylactic reaction in one patient. Development of these antibodies could not be predicted by lymphoproliferative assays. In these assays, however, the T101 protein strongly stimulated the mononuclear cells of the patient who reached the only complete remission of this trial. Immunologic stimulation by the MoAb thus might have played a role in this patient's antitumor response. In summary, therapy with MoAb T101 was specific but only modestly efficacious. Rapid infusion of nonmodulating doses of antibody provided excellent targeting and removal of peripheral blood T cells and might be a valid approach in future trials with immunoconjugated T101. 相似文献
106.
OBJECTIVE: Acquired aplastic anemia (AA) is a rare disorder characterized by pancytopenia and hypocellular bone marrow. Though experimental and clinical data suggest that AA represents a T cell-mediated disease, neither the immune response nor the nature of inciting antigen(s) have been characterized so far. The identification of a restricted T cell repertoire by PCR techniques in total lymphocyte populations supports an antigen-driven T cell response. In order to investigate the clonal composition, we analyzed the gene rearrangements of the T cell receptor (TCR) variable beta chain (Vbeta) at the single-cell level. PATIENTS AND METHODS: CD3(+) T lymphocytes were micromanipulated from peripheral blood and bone marrow samples of 8 AA patients and healthy controls. Subsequently amplified VDJ gene segments of the TCRVbeta chain were analyzed for functional rearrangements. More than 500 functionally rearranged TCR loci were studied for Vbeta/Jbeta gene segment usage and molecular composition of the complementary-determining region 3 (CDR3). RESULTS: In comparison to healthy controls, the Vbeta sequences confirmed a highly restricted T cell repertoire in AA patients at the single-cell level. Both in bone marrow and peripheral blood a predominance of Vbeta13 and Jbeta2S7 was observed. Furthermore, individual clonal T-cell expansion was identified in the majority of patients. However, deduced CDR3 amino acid sequences revealed a high variability without common motifs among the 8 patients. CONCLUSION: Individual clonal T-cell expansion with high diversity of the antigen-binding sites among the analyzed patients argues for the predominance of private inciting epitopes in AA. 相似文献
107.
AIM: To study the correlation between genetic polymorphism of cytochrome P450IIE1 (CYPIIE1) and fatty liver. METHODS: Peripheral blood mononuclear cells were collected in 56 patients with fatty liver, 26 patients without fatty liver and 20 normal controls. Then PCR-RFLP was used to analyze genetic polymorphism of CYPIIE1 in monocytes on the region of Pst I and Rsa I. RESULTS: The frequency of homozygotic C1 gene in patients with alcoholic fatty liver (28.6%), obese fatty liver (38.5%), or diabetic fatty liver (33.3%) was significantly lower than that of the corresponding patients without fatty liver (100%, 100% and 80% respectively), while the frequency of C2 genes, including C1/C2 and C2/C2, was significantly higher (71.4%/0%, 61.5%/0%, and 66.7%/20%) (P<0.01). The frequency distribution of the above genes of non-fatty liver patients (100%/0, 100%/0, and 80%/20%) was not significantly different from that of the normal controls (85%/15%) (P>0.05). CONCLUSION: The genetic polymorphism of CYPIIE1 on the position of Pst I and Rsa I is related to the susceptibility of fatty liver. Besides, C2 gene may play a key role in the pathogenesis of fatty liver. 相似文献
108.
慢性乙型肝炎的疫苗治疗免疫学机制的探讨 总被引:5,自引:0,他引:5
通过对乙型肝炎疫苗治疗的13例患者的观察,分析乙型肝炎表面抗原特异细胞增殖反应及其抗原特异性T细胞分泌的细胞因子水平,以及观察疫苗治疗后的临床效果,探讨肝炎疫苗治疗慢性乙型肝炎的免疫学作用机制。血清HBVDNA水平在疫苗治疗结束后6个月显著地下降。疫苗治疗诱生6例抗原特异性CD4 T细胞的增殖反应(38 5 % ) ,同时分泌高水平的干扰素-γ和肿瘤坏死因子-α。血清HBVDNA水平在疫苗治疗结束6个月和18个月显著下降。表面抗原特异性CD4 T细胞可以间接地抑制HBV的复制,是由抗病毒细胞因子来介导 相似文献
109.
Morphological and serum hyaluronic acid, laminin and type Ⅳ collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats 总被引:5,自引:0,他引:5
Chun-Hui Li Dong-Ming Piao Zheng-Ri Yin Jing-Shun Jin Zhe-Shi Shen Department of Pathology Affiliated Hospital of Yanbian University College of Medicine Yanji Jilin Province China Wen-Xie Xu Department of Physiology College of Medicine Shanghai Jiaotong University Shanghai China Chun-Hui Li Affiliated Hospital of Chengde Medical College Chengde Hebei Province China 《World journal of gastroenterology : WJG》2005,(48)
AIM: To study the morphological and serum hyaluronic acid (HA), laminin (LN), and type Ⅳ collagen changes in hepatic fibrosis of rats induced by dimethylnitrosamine (DMN). METHODS: The rat model of liver fibrosis was induced by DMN. Serum HA, type Ⅳ collagen, and LN were measured by ELISA. The liver/weight index and morphological changes were examined under electron microscope on d 7, 14, 21, and 28 by immunohistochemical alpha smooth muscle actin α-SMA staining as well as Sirius-red and HE staining. RESULTS: The levels of serum HA, type Ⅳ collagen and LN significantly increased from d 7 to d 28 (P = 0.043). The liver/weight index increased on d 7 and decreased on d 28. In the model group, the rat liver stained with HE and Sirius-red showed evident hemorrhage and necrosis in the central vein of hepatic 10 lobules on d 7. Thin fibrotic septa were formed joining central areas of the liver on d 14. The number of α-SMA positive cells was markedly increased in the model group. Transitional hepatic stellate cells were observed under electron microscope. All rats in the model group showed micronodular fibrosis in the hepatic parenchyma and a network of α-SMA positive cells. Typical myofibroblasts were embedded in the core of a fibrous septum. Compared to the control group, the area-density percentage of collagen fibrosis and pathologic grading were significantly different in the model group (P<0.05) on different d (7, 14, and 28). The area-density percentage of collagen fibrosis in hepatic tissue had a positive correlation with the levels of serum HA, LN, and type Ⅳ collagen. CONCLUSION: The morphological and serum HA, type Ⅳ collagen, and LN are changed in DMN-induced liver fibrosis in rats. 相似文献
110.
Rong Wang Shu Tao Yves Balkanski Philippe Ciais Olivier Boucher Junfeng Liu Shilong Piao Huizhong Shen Maria Raffaella Vuolo Myrto Valari Han Chen Yuanchen Chen Anne Cozic Ye Huang Bengang Li Wei Li Guofeng Shen Bin Wang Yanyan Zhang 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(7):2459-2463
Black carbon (BC) is increasingly recognized as a significant air pollutant with harmful effects on human health, either in its own right or as a carrier of other chemicals. The adverse impact is of particular concern in those developing regions with high emissions and a growing population density. The results of recent studies indicate that BC emissions could be underestimated by a factor of 2–3 and this is particularly true for the hot-spot Asian region. Here we present a unique inventory at 10-km resolution based on a recently published global fuel consumption data product and updated emission factor measurements. The unique inventory is coupled to an Asia-nested (∼50 km) atmospheric model and used to calculate the global population exposure to BC with fully quantified uncertainty. Evaluating the modeled surface BC concentrations against observations reveals great improvement. The bias is reduced from −88% to −35% in Asia when the unique inventory and higher-resolution model replace a previous inventory combined with a coarse-resolution model. The bias can be further reduced to −12% by downscaling to 10 km using emission as a proxy. Our estimated global population-weighted BC exposure concentration constrained by observations is 2.14 μg⋅m−3; 130% higher than that obtained using less detailed inventories and low-resolution models.Black carbon (BC), or soot, emitted from incomplete combustion of carbonaceous fuels is an air pollutant which also plays an important role in climate change (1). BC is an indicator of air particulate pollution and BC in ambient air has an impact on human health (2). In a recent study in China, it was found that the effects of BC on morbidity appear to be more robust than the effects of fine particles in general (3, 4).However, global atmospheric aerosol models often underestimate the concentration of BC at the surface, particularly over Asia, by a factor that typically ranges from 2 to 10 (5–7). In one study, the observed BC surface concentration for China could only be reproduced by doubling the emissions prescribed to a transport model (8). It is often argued that the underestimation is due to a low bias in BC emission inventories, suggesting a need to revisit these previous inventories (9).In a bottom-up approach, BC emission is estimated based on the amount of fuel consumed and an emission factor (EFBC, defined as the amount of BC emitted per unit mass of fuel consumed) for each of various combustion sources. For previous inventories, the lack of EFBC measurements in developing countries led to high uncertainty in estimating the total emissions (10). In addition, the use of fuel data at the national level is likely to distort the geographical distribution of emissions within large countries such as China and India (11). Recently, a 0.1° × 0.1° fuel database with 64 types of combustion has been developed based on local or national fuel consumption statistics. This database improves the resolution of the spatial distribution of emissions for large countries (12). To fill the data gap in developing countries, a set of EFBC values has been compiled for various residential solid fuel combustion devices and vehicles (13–20). In addition to the problems with the emission inventories, the coarse resolution of existing global aerosol models also hinders our ability to capture detailed spatial variation, leading to poor agreement between model prediction and observations (7).In this study we develop and evaluate a unique global BC emission inventory using a zoomed aerosol model, and estimate the global population’s exposure to BC with a focus on Asia. The influence of model resolution and the use of an updated emission inventory on the calculated BC concentration are evaluated against field observations. 相似文献